All patients showed greater CD8 T cell density inside the tumor compared to the non-malignant adjacent tissue, but this was significantly greater in patients with a detectable circulating tumor-reactive CD8 response (p = 0.02; Figure 4C). The gene discussed is CD8A; the disease is neoplasm.